Small Molecules, Monoclonal Antibodies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
21
NCT05345769
Safety and Efficacy of AM712 in Patients with NAMD
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 28, 2022
Completion: Nov 4, 2024
Loading map...